{"id":"https://openalex.org/W2047340911","doi":"https://doi.org/10.1371/journal.pone.0054923","title":"A Novel Angiopoietin-2 Selective Fully Human Antibody with Potent Anti-Tumoral and Anti-Angiogenic Efficacy and Superior Side Effect Profile Compared to Pan-Angiopoietin-1/-2 Inhibitors","display_name":"A Novel Angiopoietin-2 Selective Fully Human Antibody with Potent Anti-Tumoral and Anti-Angiogenic Efficacy and Superior Side Effect Profile Compared to Pan-Angiopoietin-1/-2 Inhibitors","alternate_titles":[],"publication_year":2013,"publication_date":"2013-02-06","ids":{"openalex":"https://openalex.org/W2047340911","doi":"https://doi.org/10.1371/journal.pone.0054923","mag":"2047340911","pmid":"https://pubmed.ncbi.nlm.nih.gov/23405099","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3566157"},"language":"en","primary_location":{"id":"doi:10.1371/journal.pone.0054923","doi":"https://doi.org/10.1371/journal.pone.0054923","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0054923","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0054923&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2047340911"],"child_works_count":13,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0054923&type=printable","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103478172","display_name":"Markus Thomas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094361","display_name":"Roche Pharma AG (Germany)","ror":"https://ror.org/00sh68184","country_code":"DE","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210094361"]}],"countries":["DE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Markus Thomas","raw_affiliation_strings":["Discovery Oncology, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany. markus.thomas@roche.com","Discovery Oncology, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Oncology, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany. markus.thomas@roche.com","institution_ids":["https://openalex.org/I4210094361"]},{"raw_affiliation_string":"Discovery Oncology, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany","institution_ids":["https://openalex.org/I4210094361"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061478554","display_name":"Yvonne Kienast","orcid":"https://orcid.org/0000-0002-6623-5836","observed_orcids":["https://orcid.org/0000-0002-6623-5836"]},"institutions":[{"id":"https://openalex.org/I4210094361","display_name":"Roche Pharma AG (Germany)","ror":"https://ror.org/00sh68184","country_code":"DE","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210094361"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yvonne Kienast","raw_affiliation_strings":["Discovery Oncology, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Oncology, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany","institution_ids":["https://openalex.org/I4210094361"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073502196","display_name":"Werner Scheuer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094361","display_name":"Roche Pharma AG (Germany)","ror":"https://ror.org/00sh68184","country_code":"DE","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210094361"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Werner Scheuer","raw_affiliation_strings":["Discovery Oncology, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Oncology, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany","institution_ids":["https://openalex.org/I4210094361"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038152769","display_name":"Monika B\u00e4hner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Monika B\u00e4hner","raw_affiliation_strings":["Biologics Research, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biologics Research, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027440117","display_name":"Klaus Kaluza","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Klaus Kaluza","raw_affiliation_strings":["Biologics Research, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biologics Research, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000980645","display_name":"Christian Gassner","orcid":"https://orcid.org/0000-0003-4794-2778","observed_orcids":["https://orcid.org/0000-0003-4794-2778"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christian Gassner","raw_affiliation_strings":["Biologics Research, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biologics Research, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007078235","display_name":"Frank Herting","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094361","display_name":"Roche Pharma AG (Germany)","ror":"https://ror.org/00sh68184","country_code":"DE","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210094361"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Frank Herting","raw_affiliation_strings":["Discovery Oncology, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Oncology, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany","institution_ids":["https://openalex.org/I4210094361"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055990904","display_name":"Ulrich Brinkmann","orcid":"https://orcid.org/0000-0002-5558-0212","observed_orcids":["https://orcid.org/0000-0002-5558-0212"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ulrich Brinkmann","raw_affiliation_strings":["Biologics Research, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biologics Research, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112081830","display_name":"Stefan Seeber","orcid":"https://orcid.org/0009-0009-2703-4925","observed_orcids":["https://orcid.org/0009-0009-2703-4925"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stefan Seeber","raw_affiliation_strings":["Biologics Research, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biologics Research, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079815305","display_name":"Anita Kavlie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anita Kavlie","raw_affiliation_strings":["Affitech Research AS, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Affitech Research AS, Oslo, Norway","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000124300","display_name":"Martin Welschof","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Martin Welschof","raw_affiliation_strings":["Affitech Research AS, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Affitech Research AS, Oslo, Norway","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042258509","display_name":"Stefan J. Ries","orcid":"https://orcid.org/0000-0001-5291-8276","observed_orcids":["https://orcid.org/0000-0001-5291-8276"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stefan Ries","raw_affiliation_strings":["Biologics Research, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biologics Research, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055108577","display_name":"K. Michael Weidner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094361","display_name":"Roche Pharma AG (Germany)","ror":"https://ror.org/00sh68184","country_code":"DE","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210094361"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"K. Michael Weidner","raw_affiliation_strings":["Discovery Oncology, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Oncology, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany","institution_ids":["https://openalex.org/I4210094361"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038036806","display_name":"J\u00f6rg T. Regula","orcid":"https://orcid.org/0000-0002-7343-1077","observed_orcids":["https://orcid.org/0000-0002-7343-1077"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J\u00f6rg T. Regula","raw_affiliation_strings":["Biologics Research, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biologics Research, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067162282","display_name":"Christian Klein","orcid":"https://orcid.org/0000-0001-7594-7280","observed_orcids":["https://orcid.org/0000-0001-7594-7280"]},"institutions":[{"id":"https://openalex.org/I4210094361","display_name":"Roche Pharma AG (Germany)","ror":"https://ror.org/00sh68184","country_code":"DE","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210094361"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christian Klein","raw_affiliation_strings":["Discovery Oncology, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Oncology, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany","institution_ids":["https://openalex.org/I4210094361"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5103478172"],"corresponding_institution_ids":["https://openalex.org/I4210094361"],"apc_list":{"value":2382,"currency":"USD","value_usd":2382},"apc_paid":{"value":2382,"currency":"USD","value_usd":2382},"fwci":3.3274,"has_fulltext":true,"cited_by_count":76,"citation_normalized_percentile":{"value":0.94200487,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"8","issue":"2","first_page":"e54923","last_page":"e54923"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11469","display_name":"Lymphatic System and Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/angiopoietin-2","display_name":"angiopoietin-2","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tie2-receptor","display_name":"Tie2 receptor","score":0.7289999723434448},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.8709999918937683},{"id":"https://openalex.org/keywords/tumor-angiogenesis","display_name":"tumor angiogenesis","score":0.9829999804496765},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.8880000114440918},{"id":"https://openalex.org/keywords/tumor-necrosis","display_name":"tumor necrosis","score":0.6549999713897705},{"id":"https://openalex.org/keywords/tumor-microvessel-density","display_name":"tumor microvessel density","score":0.7279999852180481},{"id":"https://openalex.org/keywords/pericyte-coverage","display_name":"pericyte coverage","score":0.9340000152587891},{"id":"https://openalex.org/keywords/lung-metastasis","display_name":"lung metastasis","score":0.8460000157356262},{"id":"https://openalex.org/keywords/angiopoietin-1","display_name":"angiopoietin-1","score":0.6880000233650208}],"concepts":[{"id":"https://openalex.org/C85219853","wikidata":"https://www.wikidata.org/wiki/Q4763284","display_name":"Angiopoietin receptor","level":3,"score":0.824062705039978},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.6904577612876892},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.678896427154541},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6002489924430847},{"id":"https://openalex.org/C2780427682","wikidata":"https://www.wikidata.org/wiki/Q500446","display_name":"Pericyte","level":4,"score":0.5399631857872009},{"id":"https://openalex.org/C2779094623","wikidata":"https://www.wikidata.org/wiki/Q539710","display_name":"Angiopoietin","level":4,"score":0.5110050439834595},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.5001766681671143},{"id":"https://openalex.org/C2778271429","wikidata":"https://www.wikidata.org/wiki/Q1281049","display_name":"Neovascularization","level":3,"score":0.47820472717285156},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.4578832685947418},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4303804337978363},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41876351833343506},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36667168140411377},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.35683727264404297},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.34995242953300476},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2985934615135193},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27669644355773926},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.1775391697883606},{"id":"https://openalex.org/C123012128","wikidata":"https://www.wikidata.org/wiki/Q5376430","display_name":"Endothelial stem cell","level":3,"score":0.13786116242408752},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1201886534690857},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.10534393787384033},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000918","descriptor_name":"Antibody Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":true},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D003315","descriptor_name":"Cornea","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003315","descriptor_name":"Cornea","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011897","descriptor_name":"Random Allocation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016513","descriptor_name":"Mice, SCID","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D042683","descriptor_name":"Angiopoietin-1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D042683","descriptor_name":"Angiopoietin-1","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D042702","descriptor_name":"Angiopoietin-2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D042702","descriptor_name":"Angiopoietin-2","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D042787","descriptor_name":"Receptor, TIE-2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D042787","descriptor_name":"Receptor, TIE-2","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055806","descriptor_name":"Microvessels","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D055806","descriptor_name":"Microvessels","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D057134","descriptor_name":"Antibodies, Neutralizing","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D057134","descriptor_name":"Antibodies, Neutralizing","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D057809","descriptor_name":"HEK293 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1371/journal.pone.0054923","doi":"https://doi.org/10.1371/journal.pone.0054923","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0054923","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0054923&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2569908","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3566157","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3566157","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3566157/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS One","raw_type":"Text"},{"id":"pmid:23405099","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23405099","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PloS one","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:bc383949771b43a4a38b519f5fd75a2a","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/bc383949771b43a4a38b519f5fd75a2a","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS ONE, Vol 8, Iss 2, p e54923 (2013)","raw_type":"article"},{"id":"pmh:oai:figshare.com:article/155912","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/A_Novel_Angiopoietin_2_Selective_Fully_Human_Antibody_with_Potent_Anti_Tumoral_and_Anti_Angiogenic_Efficacy_and_Superior_Side_Effect_Profile_Compared_to_Pan_Angiopoietin_1_2_Inhibitors__/155912","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"}],"best_oa_location":{"id":"doi:10.1371/journal.pone.0054923","doi":"https://doi.org/10.1371/journal.pone.0054923","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0054923","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0054923&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2047340911.pdf","grobid_xml":"https://content.openalex.org/works/W2047340911.grobid-xml"},"referenced_works_count":55,"referenced_works":["https://openalex.org/W16277683","https://openalex.org/W1491061797","https://openalex.org/W1498167302","https://openalex.org/W1531163264","https://openalex.org/W1562355542","https://openalex.org/W1967600348","https://openalex.org/W1970614272","https://openalex.org/W1972344356","https://openalex.org/W1974218755","https://openalex.org/W1977587080","https://openalex.org/W1977721830","https://openalex.org/W1977924667","https://openalex.org/W1978157267","https://openalex.org/W1979774149","https://openalex.org/W1980037409","https://openalex.org/W1987608491","https://openalex.org/W1992423971","https://openalex.org/W1996859043","https://openalex.org/W1997761243","https://openalex.org/W2003788548","https://openalex.org/W2012255417","https://openalex.org/W2014901738","https://openalex.org/W2036180243","https://openalex.org/W2042350316","https://openalex.org/W2054331246","https://openalex.org/W2066888615","https://openalex.org/W2077746894","https://openalex.org/W2081596239","https://openalex.org/W2084452119","https://openalex.org/W2085054303","https://openalex.org/W2087486104","https://openalex.org/W2093630402","https://openalex.org/W2095235698","https://openalex.org/W2100415431","https://openalex.org/W2108360509","https://openalex.org/W2113920157","https://openalex.org/W2118185746","https://openalex.org/W2120022879","https://openalex.org/W2120711861","https://openalex.org/W2122927195","https://openalex.org/W2127286131","https://openalex.org/W2131393213","https://openalex.org/W2132827381","https://openalex.org/W2136480937","https://openalex.org/W2138687800","https://openalex.org/W2140088548","https://openalex.org/W2141674582","https://openalex.org/W2145267522","https://openalex.org/W2145441158","https://openalex.org/W2147581368","https://openalex.org/W2150487692","https://openalex.org/W2152215024","https://openalex.org/W2154812962","https://openalex.org/W2164008484","https://openalex.org/W2416021581"],"related_works":["https://openalex.org/W1996859043","https://openalex.org/W1998564537","https://openalex.org/W2170000965","https://openalex.org/W1966550470","https://openalex.org/W2119468857","https://openalex.org/W2011429088","https://openalex.org/W1974218755","https://openalex.org/W2042247764","https://openalex.org/W2099028752","https://openalex.org/W2108360509"],"abstract_inverted_index":{"There":[0],"is":[1,20],"increasing":[2],"experimental":[3],"evidence":[4,203],"for":[5,82,204,215],"an":[6,93],"important":[7],"role":[8,35],"of":[9,36,55,126,148,168,218],"Angiopoietin-2":[10],"(Ang-2)":[11],"in":[12,22,39,104,113,155,171],"tumor":[13,40,106,111,117,131,149,189],"angiogenesis":[14],"and":[15,26,42,65,70,109,115,130,137],"progression.":[16],"In":[17],"addition,":[18],"Ang-2":[19,37,56,72,83,101,207],"up-regulated":[21],"many":[23],"cancer":[24],"types":[25],"correlated":[27],"with":[28,73,123,177],"poor":[29],"prognosis.":[30],"To":[31],"investigate":[32],"the":[33,53,146,152,158,172,175,178,205,216],"functional":[34],"inhibition":[38,108,176],"development":[41],"progression,":[43],"we":[44],"generated":[45],"novel":[46],"fully":[47],"human":[48,71],"antibodies":[49,63],"that":[50,100,163],"neutralize":[51],"specifically":[52],"binding":[54],"to":[57,87,151,157,165,184,188],"its":[58],"receptor":[59],"Tie2.":[60],"The":[61],"selected":[62],"LC06":[64,77,182,209],"LC08":[66,88,162],"recognize":[67],"both":[68],"rodent":[69],"high":[74],"affinity,":[75],"but":[76],"shows":[78],"a":[79,124,166],"higher":[80],"selectivity":[81],"over":[84],"Ang-1":[85],"compared":[86],"which":[89],"can":[90],"be":[91,185],"considered":[92],"Ang-2/Ang-1":[94,159],"cross-reactive":[95,160],"antibody.":[96],"Our":[97],"data":[98,200],"demonstrate":[99],"blockade":[102],"results":[103],"potent":[105],"growth":[107],"pronounced":[110],"necrosis":[112],"subcutaneous":[114],"orthotopic":[116],"models.":[118],"These":[119],"effects":[120,193],"are":[121],"attended":[122],"reduction":[125],"intratumoral":[127],"microvessel":[128],"density":[129],"vessels":[132,170],"characterized":[133],"by":[134],"fewer":[135],"branches":[136],"increased":[138],"pericyte":[139],"coverage.":[140],"Furthermore,":[141],"anti-Ang-2":[142,180],"treatment":[143,217],"strongly":[144],"inhibits":[145],"dissemination":[147],"cells":[150],"lungs.":[153],"Interestingly,":[154],"contrast":[156],"antibody":[161,181,208],"leads":[164],"regression":[167],"physiological":[169],"mouse":[173],"trachea,":[174],"selective":[179,206],"appears":[183],"largely":[186],"restricted":[187],"vasculature":[190],"without":[191],"obvious":[192],"on":[194],"normal":[195],"vasculature.":[196],"Taken":[197],"together,":[198],"these":[199],"provide":[201],"strong":[202],"as":[210],"promising":[211],"new":[212],"therapeutic":[213],"agent":[214],"various":[219],"cancers.":[220]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2047340911","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":14},{"year":2015,"cited_by_count":12},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":4}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
